S16 From whence comes HSDD? - The Journal of Family Practice

Supplement toinstructions forreceiving creditContinuing Education CreditThere are 2 optionsfor receiving credit:Option 1:The DIME online enrollment systema. Please visit the url:www.DIMedEd.org/updates/HSDDFamilyPractice.htmlb. Complete the enrollment form,posttest, and evaluation.c. Successful completion of the selfassessmentis required to earnCategory 1 CME credit. Successfulcompletion is defined as a cumulativescore of at least 70% correct. If youreceive a passing score, your certificateof credit will be made available to youimmediately.If you have difficulty accessing thelink, please contact the DIME officeat (312) 553-8000 or dimeservices@DIMedEd.orgOption 2:Complete this enrollment form,posttest, and evaluation form andmail them to:DIME 17771222 Merchandise Mart PlazaSuite 4-160Chicago, IL 60654A certificate of credit will be e-mailedor mailed to you within 6 weeks.EDUCATIONAL OUTCOMESQUESTIONSRelease date: July 15, 2009Expiration date: July 15, 2010Estimated time to complete activity: 1.25 hoursEvaluation questionsPlease answer to the best of your ability. These questions are not graded and your answers will NOT affect your CME credit.1. In prevalence studies of sexual dysfunction, whichof the following is the most common sexual complaintreported by women?a. Orgasm difficulties c. Low sexual desireb. Low sexual arousal d. Pain with intercourse2. A 57-year-old woman presents for a new patient visitand examination. She stopped menstruating at age 51and received combination estrogen/progestin therapyfor several years to alleviate vasomotor symptoms butdiscontinued use. She reports no significant medicalhistory. On the patient intake checklist she notedpain during intercourse and, upon questioning,reports a progressive decrease in sexual desire sincethe menopause transition. Her husband complainsabout her lack of desire; however, she is satisfied withher current sexual activity and does not feel that itnegatively affects her relationship. What would beyour diagnosis for this patient?a. Dyspareunia c. Sexual aversion disorderb. Situational hypoactive d. Generalized HSDDsexual desire disorder(HSDD)3. What treatment strategy would you select for thispatient?a. Administer compounded testosterone to increase sexualdesireb. Administer local estrogen to relieve pain during intercoursec. Administer systemic estrogen to relieve pain duringintercourse and increase desired. Refer to a sex therapist4. A wide range of pharmacologic agents have beenevaluated for their efficacy in the treatment of HSDD.Which of the following mechanisms of action has notbeen investigated for the treatment of HSDD?a. Testosterone formulationsb. 5-HY1A serotonin receptor agonist/5-HT2A serotoninreceptor antagonistc. Melanocortin receptor agonistd. Serotonin-noradrenaline reuptake inhibitorLast nameFirst name, InitialAcademic TitleAffiliationSpecialtyStreet or PO BoxCityStatEPhoneFaxe-mailENROLLMENT FORMREQUEST FOR CREDIT (PLEASE PRINT)degree(s)Zip CodeTo receive the information you are requesting, please make certain your contactinformation is legible.Overall Enduring MaterialEvaluation5=Excellent, 4=Good, 3=Satisfactory,2=Fair, 1=PoorUsing the above scale, please evaluatethis activity by marking the appropriateresponse.1. Objectivity and balance5 4 3 2 12. Did you perceive any bias orcommercialism in this activity towardany product or drug?n Yes3. Scientific rigorn No If Yes, please explain5 4 3 2 14. Amount of information presented5 4 3 2 15. Level of instruction5 4 3 2 1Learning Objectives5=Strongly agree, 4=Agree, 3=Neutral,2=Disagree, 1=Strongly disagreeUsing the above scale, indicate whether aftercompleting this activity you are better able to:6. Define HSDD and identify thefactors associated with it or thatmay contribute to it.5 4 3 2 17. Describe the steps required fortaking a thorough and clinicallypertinent sexual history.5 4 3 2 18. Explain how to screen patients forHSDD, how to identify and diagnosepatients at risk for HSDD, and how torefer them to appropriate resources.5 4 3 2 19. Identify interventions andpharmacologic treatments forHSDD and provide evidence of theireffectiveness.5 4 3 2 110. Discuss patient and providerobstacles to the recognition andmanagement of HSDD and identifystrategies for overcoming thesebarriers.5 4 3 2 1Reason for Participation5=Extremely, 4=Very, 3=Somewhat,2=Not very, 1=Not at allUsing the above scale, indicate how importantthe following reasons are for your participationin educational activities.11. Topics5 4 3 2 112. Faculty/editor’s reputation5 4 3 2 113. CME credit5 4 3 2 114. As a result of participating in thisactivity, did you learn anything thatwould cause you to make a changein your clinical practice (chooseonly one)?■ Yes, I am going to try toincorporate some of the informationpresented into my clinical practice■ No, I am not going toincorporate any of the informationinto my clinical practice15. If yes, how soon do you intend toincorporate changes in your practice asa result of this CME activity?■ Immediately■ In 1 month■ In 3 months■ In 6 months■ I do not know16. If no, why not?■ I learned some new information,but the information presented is notapplicable to my clinical practice■ The information presented confirmedmy current clinical practice■ I did not find the informationuseful and I will not change mycurrent clinical practice■ I do not know17. Please indicate whether you wouldrecommend this activity to others.■ Yes■ No18. Please rate your interest in the followingeducational topics for HSDD from 5(highest interest) to 1 (lowest interest):___ Definitions of FSD___ Emerging treatment strategiesfor HSDD___ Psychosocial aspects of FSD___ Diagnosing HSDD___ Referral strategies for FSD___ Screening tools for FSD___ Available treatments for HSDD___ Etiology of FSD/HSDD___ Approaches to taking a sexual history19. Additional comments:S34 July 2009 / Vol 58, No 7 / Supplement to The Journal of Family Practice Copyright © 2009 Dowden Health Media and DIME www.jfponline.comSupplement to The Journal of Family Practice / Vol 58, No 7 / July 2009 S35